Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: A retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation

Haematologica

Volumn 93, Issue 8, 2008, Pages 1203-1210

  Tichelli, André ^a   Passweg, Jakob ^b   Wójcik, Dorota ^c   Rovó, Alicia ^a   Harousseau, Jean Luc ^d   Masszi, Tamas ^e   Zander, Axel ^f   Békássy, Albert ^g   Crawley, Charles ^h   Arat, Mutlu ⁱ   Sica, Simona ^j   Lutz, Patrick ^k   Socié, Gérard ^l  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c WROCLAW MEDICAL UNIVERSITY   (Poland)

^d HÔTEL DIEU   (France)

^e Szent Laszlo Hospital   (Hungary)

^f UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^g LUND UNIVERSITY HOSPITAL   (Sweden)

^h ADDENBROOKE S HOSPITAL   (United Kingdom)

ⁱ ANKARA UNIVERSITY   (Turkey)

^j CATHOLIC UNIVERSITY   (Italy)

^k HÔPITAL DE HAUTEPIERRE   (France)

^l SAINT LOUIS HOSPITAL   (France)

more..

Author keywords

Cardiovascular; Late effects; Long term survivors; Stem cell transplantation

Indexed keywords

ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; EVALUATION; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; IMMOBILIZATION; INCIDENCE; MALE; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDY; SMOKING; SURVIVAL; SURVIVOR; WEIGHT GAIN;

ADULT; AGED; ARTERIAL OCCLUSIVE DISEASES; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; CARDIOVASCULAR DISEASES; CORONARY DISEASE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SURVIVAL RATE; SURVIVORS; TIME FACTORS;

EID: 48749091809     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.12949     Document Type: Article

References (36)

1. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med 2006;354:1813-26.
2. Socié G, Salooja N, Cohen A, Rovelli A, Carreras E, Locasciulli A, et al. Nonmalignant late effects after allogeneic stem cell transplantation. Late Effects Working Party of the European Study Group for Blood and Marrow Transplantation. Blood 2003;101:3373-85.
3. Ades L, Guardiola P, Socie G. Second malignancies after allogeneic hematopoietic stem cell transplantation: new insight and current problems. Blood Rev 2002;16:135-46.
4. Ferry C, Socie G. Busulfan-cyclophosphamide versus total body irradiation-cyclophosphamide as preparative regimen before allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia: what have we learned? Exp Hematol 2003;31:1182-6.
5. Tichelli A, Socie G. Considerations for adult cancer survivors. Hematology (Am Soc Hematol Educ Program) 2005;516-22.
6. Tichelli A, Gratwohl A, Egger T, Roth J, Prünte A, Nissen C, et al. Cataract formation after bone marrow transplantation. Ann Intern Med 1993;119:1175-80.
7. Soubani AO, Miller KB, Hassoun PM. Pulmonary complications of bone marrow transplantation. Chest 1996;109:1066-77.
8. Salooja N, Szydlo RM, Socie G, Rio B, Chatterjee R, Ljungman P, et al. Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey. Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Lancet 2001;358:271-6.
9. Legault L, Bonny Y. Endocrine complications of bone marrow transplantation in children. Pediatr Transplant 1999;3:60-6.
10. Kolb HJ, Socié G, Duell T, Van Lint MT, Tichelli A, Apperley JF, et al. Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group. Ann Intern Med 1999;131:738-44.
11. Elkind MS. Inflammation, atherosclerosis, and stroke. Neurologist 2006;12:140-8.
12. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-95.
13. Stoll G, Bendszus M. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke 2006;37:1923-32.
14. Lloyd-Jones DM, Leip EP, Larson MG, D'Agostino RB, Beiser A, Wilson PW, et al. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation 2006;113:791-8.
15. Basavaraju SR, Easterly CE. Pathophysiological effects of radiation on atherosclerosis development and progression, and the incidence of cardiovascular complications. Med Phys 2002;29:2391-403.
16. Schultz-Hector S. Radiation-induced heart disease: review of experimental data on dose response and pathogenesis. Int J Radiat Biol 1992;61:149-60.
17. Biedermann BC, Sahner S, Gregor M, Tsakiris DA, Jeanneret C, Pober JS, et al. Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease. Lancet 2002;359:2078-83.
18. Taskinen M, Saarinen-Pihkala UM, Hovi L, Lipsanen-Nyman M. Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood. Lancet 2000;356:993-7.
19. Coplin WM, Cochran MS, Levine SR, Crawford SW. Stroke after bone marrow transplantation: frequency, aetiology and outcome. Brain 2001;124:1043-51.
20. Gatt ME, Liebster D, Leibowitz D, Matzner Y. Acute myocardial infarction after bone marrow transplantation: an unsuspected late complication. Ann Hematol 2003;82:136-8.
21. Ghobrial IM, Bunch TJ, Caplice NM, Edwards WD, Miller DV, Litzow MR. Fatal coronary artery disease after unrelated donor bone marrow transplantation. Mayo Clin Proc 2004; 79:403-6.
22. Gordon BG, Saving KL, McCallister JA, Warkentin PI, McConnell JR, Roberts WM, et al. Cerebral infarction associated with protein C deficiency following allogeneic bone marrow transplantation. Bone Marrow Transplant 1991;8:323-5.
23. Uchida N, Taniguchi S, Harada N, Shibuya T. Myocardial ischemia following allogeneic bone marrow transplantation: possible implication of tacrolimus overdose. Blood 2000;96:370-2.
24. van der LJ, Louwerse ES, Thomas LL, van Oers MH, dem Borne AE. Acute ischaemic cerebrovascular accident after autologous bone marrow transplantation. Eur J Haematol 1996;56:95-7.
25. Wang B, Cao LX, Liu HL, Jiang M, Hu LD. Myocardial infarction following allogeneic bone marrow transplantation. Bone Marrow Transplant 1996;18:479-80.
26. Baker KS, Gurney JG, Ness KK, Bhatia R, Forman SJ, Francisco L, et al. Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the Bone Marrow Transplant Survivor Study. Blood 2004;104:1898-906.
27. Tichelli A, Bucher C, Rovó A, Stussi G, Stern M, Paulussen M, et al. Premature cardiovascular disease after allogeneic stem cell transplantation. Blood 2007;110:3463-71.
28. Taskinen M, Saarinen-Pihkala UM, Hovi L, Lipsanen-Nyman M. Impaired glucose tolerance and dyslipidaemia as late effects after bonemarrow transplantation in childhood. Lancet 2000;356:993-7.
29. Couriel DR, Saliba R, Escalón MP, Hsu Y, Ghosh S, Ippoliti C, et al. Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease. Br J Haematol 2005;130:409-17.
30. Tichelli A, Gratwohl A. Vascular endothelium as 'novel' target of graft-versus-host disease. Best Pract Res Clin Haematol 2008;21:139-48.
31. Sviland L, Sale GE, Myerson D. Endothelial changes in cutaneous graft-versus-host disease: a comparison between HLA matched and mismatched recipients of bone marrow transplantation. Bone Marrow Transplant. 1991;7:35-8.
32. Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980;69:204-17.
33. Dumler JS, Beschorner WE, Farmer ER, Di Gennaro KA, Saral R, Santos GW. Endothelial-cell injury in cutaneous acute graft-versus-host disease. Am J Pathol 1989;135:1097-103.
34. Murata H, Janin A, Leboeuf C, Soulier J, Gluckman E, Meignin V, Socie G. Donor-derived cells and human graft-versus-host disease of the skin. Blood 2007;109:2663-5.
35. Cowie MR, Wood DA, Coats AJ, Thompson SG, Poole-Wilson PA, Suresh V, Sutton GC. Incidence and aetiology of heart failure; a population-based study. Eur Heart J 1999;20:421-8.
36. National Institutes of Health, National Heart, Lung, and Blood Institute. Incidence and Prevalence: 2006 Chart Book on Cardiovascular and Lung Diseases. Bethesda, MD: National Heart, Lung, and Blood Institute; 2006. Available at: http://www.nhlbi.nih.gov/resources/docs/06a_ip_chtbk.pdf. Accessed October 17, 2007.